Summary of Rockwell Medical's Q3 2025 Earnings Call

1Key Financial Results and Metrics

Net Sales: $15.9 million, a 44% decrease from $28.3 million in Q3 2024, attributed to the transition of the largest customer to another supplier.

Gross Profit: $2.3 million, down 64% from $6.2 million in Q3 2024.

Gross Margin: 14%, down from 22% in Q3 2024; adjusted gross margin (excluding restructuring costs) was 18%.

Net Loss: $1.8 million, compared to a net income of $1.7 million in Q3 2024.

Adjusted EBITDA: $50,000, an improvement from negative $200,000 in Q2 2025 and negative $400,000 in Q1 2025.

Cash Position: Increased to $23.7 million from $18.4 million at the end of Q2 2025.

2Strategic Updates and Business Highlights

Rockwell Medical is managing the transition of its largest customer while securing long-term contracts with over 80% of its customer base, providing stability and revenue visibility.

New long-term agreements were signed with various medical centers, including a notable $1 million annualized net sales agreement with a dialysis center in Southern Florida.

The company is actively pursuing growth opportunities and has a pipeline of potential new customers across different segments and geographies.

The introduction of a new bicarbonate cartridge is expected to enhance margins and sales.

3Forward Guidance and Outlook

Rockwell Medical anticipates being able to provide revenue guidance for 2026 during the release of its fourth-quarter earnings.

The company remains confident in achieving its full-year guidance targets and expects to see continued improvement in financial performance as new customer relationships develop.

4Bad News, Challenges, or Points of Concern

The significant decline in net sales and gross profit reflects ongoing challenges due to the transition of the largest customer, which still accounted for 12% of Q3 sales.

Gross margin has decreased year-over-year, indicating potential pressures on profitability.

The company is undergoing a restructuring process, which, while aimed at improving efficiency, poses risks related to operational capacity and customer service during the transition.

5Notable Q&A Insights

Management expects the situation with the former largest customer to be resolved within the current quarter, with ongoing contract discussions.

The company is exploring acquisitions to leverage its strong cash position and is actively engaged in business development.

There is optimism regarding the growth potential of the at-home dialysis market, although it currently represents a small percentage of overall business (single digits).

Management highlighted that labor costs and material efficiencies are key areas for improving gross margins moving forward. Overall, Rockwell Medical is navigating a challenging transition period while laying the groundwork for future growth through strategic customer agreements and operational efficiencies.